These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 30278336)

  • 1. Incomplete uptake of EGFR mutation testing and its impact on estimation of mutation prevalence in patients with non-squamous NSCLC: A population-based study in New Zealand.
    Tin Tin S; McKeage MJ; Khwaounjoo P; Thi AM; Elwood JM
    Cancer Epidemiol; 2018 Dec; 57():24-32. PubMed ID: 30278336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Population-based incidence rates and increased risk of EGFR mutated non-small cell lung cancer in Māori and Pacifica in New Zealand.
    Aye PS; McKeage MJ; Tin Tin S; Khwaounjoo P; Elwood JM
    PLoS One; 2021; 16(5):e0251357. PubMed ID: 33961689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EGFR Mutation Testing of non-squamous NSCLC: Impact and Uptake during Implementation of Testing Guidelines in a Population-Based Registry Cohort from Northern New Zealand.
    McKeage M; Elwood M; Tin Tin S; Khwaounjoo P; Aye P; Li A; Sheath K; Shepherd P; Laking G; Kingston N; Lewis C; Love D
    Target Oncol; 2017 Oct; 12(5):663-675. PubMed ID: 28699084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EGFR mutation testing of lung cancer patients - Experiences from Vestfold Hospital Trust.
    Berg J; Fjellbirkeland L; Suhrke P; Jebsen P; Lund-Iversen M; Kleinberg L; Helgeland L; Brustugun OT; Helland Å
    Acta Oncol; 2016; 55(2):149-55. PubMed ID: 26313507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utilisation and Determinants of Epidermal Growth Factor Receptor Mutation Testing in Patients with Non-small Cell Lung Cancer in Routine Clinical Practice: A Global Systematic Review.
    Thi AM; Tin Tin S; McKeage M; Elwood JM
    Target Oncol; 2020 Jun; 15(3):279-299. PubMed ID: 32445082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors associated with overall survival in a population-based cohort of non- squamous NSCLC patients from northern New Zealand: A comparative analysis by EGFR mutation status.
    Aye PS; McKeage MJ; Tin Tin S; Khwaounjoo P; Elwood JM
    Cancer Epidemiol; 2020 Dec; 69():101847. PubMed ID: 33126040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EGFR mutation prevalence in Asia-Pacific and Russian patients with advanced NSCLC of adenocarcinoma and non-adenocarcinoma histology: The IGNITE study.
    Han B; Tjulandin S; Hagiwara K; Normanno N; Wulandari L; Laktionov K; Hudoyo A; He Y; Zhang YP; Wang MZ; Liu CY; Ratcliffe M; McCormack R; Reck M
    Lung Cancer; 2017 Nov; 113():37-44. PubMed ID: 29110846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidermal growth factor receptor and anaplastic lymphoma kinase testing and mutation prevalence in patients with advanced non-small cell lung cancer in Switzerland: A comprehensive evaluation of real world practices.
    Ess SM; Herrmann C; Frick H; Krapf M; Cerny T; Jochum W; Früh M
    Eur J Cancer Care (Engl); 2017 Nov; 26(6):. PubMed ID: 28557060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utilization Patterns and Trends in Epidermal Growth Factor Receptor (EGFR) Mutation Testing Among Patients With Newly Diagnosed Metastatic Lung Cancer.
    Shen C; Kehl KL; Zhao B; Simon GR; Zhou S; Giordano SH
    Clin Lung Cancer; 2017 Jul; 18(4):e233-e241. PubMed ID: 28024927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High proportion of rare and compound epidermal growth factor receptor mutations in an Australian population of non-squamous non-small-cell lung cancer.
    Stone E; Allen HA; Saghaie T; Abbott A; Daniel R; Mead RS; Kohonen-Corish M; Plit M; Morgan L
    Intern Med J; 2014 Dec; 44(12a):1188-92. PubMed ID: 25228365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidermal growth factor receptor mutation and pattern of brain metastasis in patients with non-small cell lung cancer.
    Baek MY; Ahn HK; Park KR; Park HS; Kang SM; Park I; Kim YS; Hong J; Sym SJ; Park J; Lee JH; Shin DB; Cho EK
    Korean J Intern Med; 2018 Jan; 33(1):168-175. PubMed ID: 27093978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identifying lung cancer patients who may be eligible for epidermal growth factor receptor (EGFR) mutation testing.
    Hicks K; Wong C
    N Z Med J; 2013 Aug; 126(1381):49-56. PubMed ID: 24150265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequency of EGFR mutations in non-small cell lung cancer patients: screening data from West Siberia.
    Gervas P; Ivanova A; Vasiliev N; Ananina O; Zharkova O; Rogovieva O; Verzhbitskaya N; Didichuk I; Cheremisina O; Popova N; Goldberg V; Cherdyntsev E; Choynzonov E; Cherdyntseva N
    Asian Pac J Cancer Prev; 2015; 16(2):689-92. PubMed ID: 25684509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Real-world EGFR testing in patients with stage IIIB/IV non-small-cell lung cancer in North China: A multicenter, non-interventional study.
    Cheng Y; Wang Y; Zhao J; Liu Y; Gao H; Ma K; Zhang S; Xin H; Liu J; Han C; Zhu Z; Wang Y; Chen J; Wen F; Li J; Zhang J; Zheng Z; Dai Z; Piao H; Li X; Li Y; Zhong M; Ma R; Zhuang Y; Xu Y; Qu Z; Yang H; Pan C; Yang F; Zhang D; Li B
    Thorac Cancer; 2018 Nov; 9(11):1461-1469. PubMed ID: 30253083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of EGFR mutations in newly diagnosed locally advanced or metastatic non-small cell lung cancer Spanish patients and its association with histological subtypes and clinical features: The Spanish REASON study.
    Esteban E; Majem M; Martinez Aguillo M; Martinez Banaclocha N; Dómine M; Gómez Aldaravi L; Juan O; Cajal R; Gonzalez Arenas MC; Provencio M
    Cancer Epidemiol; 2015 Jun; 39(3):291-7. PubMed ID: 25766256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Establishing an EGFR mutation screening service for non-small cell lung cancer - sample quality criteria and candidate histological predictors.
    Leary AF; Castro DG; Nicholson AG; Ashley S; Wotherspoon A; O'Brien ME; Popat S
    Eur J Cancer; 2012 Jan; 48(1):61-7. PubMed ID: 22036089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence and characteristics of Epidermal Growth Factor Receptor (EGFR) mutation in non-small-cell lung cancer (Adenocarcinoma histology): A report of 106 patients from Kolkata.
    Chatterjee K; Ray A; Chattopadhyay B
    Indian J Cancer; 2017; 54(1):305-307. PubMed ID: 29199710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and Clinical Profile of EGFR Mutation In Non- Small-Cell Lung Carcinoma Patients in Southwest China.
    Zhou J; Song XB; He H; Zhou Y; Lu XJ; Ying BW
    Asian Pac J Cancer Prev; 2016; 17(3):965-71. PubMed ID: 27039821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence-based best practices for
    Stockley T; Souza CA; Cheema PK; Melosky B; Kamel-Reid S; Tsao MS; Spatz A; Karsan A
    Curr Oncol; 2018 Apr; 25(2):163-169. PubMed ID: 29719432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Routine implementation of EGFR mutation testing in clinical practice in Flanders: 'HERMES' project.
    Janssens A; De Droogh E; Lefebure A; Kockx M; Pauwels P; Germonpre P; van Meerbeeck JP
    Acta Clin Belg; 2014 Apr; 69(2):92-7. PubMed ID: 24724747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.